Neeman & Industry News
DCGI to implement e-Gov in its working The Drugs Controller General of India (DCGI) to have a single window facility for drug approval soon...
New Indian Regulatory Guidance by Central Drugs Standard Control Organization Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy - Central Drugs Standard Control Organization...
Indian Clinical Data Management market is expected to ramp up to $150 million MNCs are more than willing to outsource their needs to India because of it\'s technological innovation, creditable quality, operational flexibility, cost effectiveness, time-to-market and competitive advantage according to Koteshwar Govind, Deputy Manager,...
India: Attractive Market for Biopharmaceutical Companies Looking to Accelerate Their Clinical Trials The Clinical Research Market in India is growing at a very rapid rate according to anyone’s statistics…It is exploding according to all the hype. ...

Neeman News

 
  Max Neeman International Continues to Expand in Response to Increased Client Demand for Medical Writing Services  
  RESEARCH TRIANGLE PARK, N.C., July 13 /PRNewswire/ -- Max Neeman International, India's premier CRO, has expanded its team of medical writers in res....  
     
  Max Neeman International Expands Data Management Services with Conversion Into CDISC Standard Data Model  
  RESEARCH TRIANGLE PARK, N.C., June 29 /PRNewswire/ -- Max Neeman International, India's premier CRO, created a niche in Data Management services and....  
     
  Max Neeman International Sets Up an Exclusive Team for Cosmetic Studies Expanding Upon Dermatology Experience  
  Max Neeman Positions for Growth of Cosmetic Industry RESEARCH TRIANGLE PARK, N.C., June 14 /PRNewswire/ -- Max Neeman International, India's premie....  
     
  Max Neeman Announces Expansion of Central Lab Services in Partnership with Max Healthcare  
  Company's Central Lab Offers an Additional Service Max Neeman Provides ....  
     
  Max Neeman International Signs Agreement for Data Management/EDC of Large Phase IV Trials from Multiple Sites  
  This landmark trial has the longest follow-up of endocrine treatment in the adjuvant switch setting with approximately 2300 patients from across the....  
     

 2 3 Next